Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-11-01 / Clin. Exp. Immunol. 2012 Nov;170(2):167-77Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2012-11-01 / J. Cell. Mol. Med. 2012 Nov;16(11):2827-37Dendritic cell-based immunotherapy in mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-10-01 / Immunotherapy 2012 Oct;4(10):1011-22Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2012-10-01 / Immunotherapy 2012 Oct;4(10):995-1009Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2012-09-11 / Int. J. Oncol. 2012 Nov;41(5):1601-9Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24Immunotherapy in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2012-08-21 / Hum Vaccin Immunother 2012 Sep;8(9):1179-91NK cells: key to success of DC-based cancer vaccines?
/in Dendritic Cells, International Publications /von 2012-08-20 / Oncologist 2012;17(10):1256-70Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2012-08-10 / Korean J. Physiol. Pharmacol. 2012 Aug;16(4):243-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de